Antipsychotic drugs increase adipose stem cell differentiation-implications for treatment with antipsychotic drugs

Journal of Clinical Psychopharmacology

Volumn 31, Issue 5, 2011, Pages 663-665

  Hemmrich, Karsten ^a   Kappel, Ben Arpad ^a   Paul, Nora Emilie ^a   Goy, Daniela ^a   Luckhaus, Christian ^b   Pallua, Norbert ^a   Fehsel, Karin ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADIPOSE DERIVED STEM CELL; APOPTOSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; PRIORITY JOURNAL; PROADIPOCYTE;

ADIPOSE TISSUE; ANTIPSYCHOTIC AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; SCHIZOPHRENIA; STEM CELLS;

EID: 80052436077     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31822bf0a5     Document Type: Letter

References (21)

1. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(suppl 1):1-93. (Pubitemid 40677047)
2. Taylor DM, McAskill R. AAPD and weight gainVa systematic review. Acta Psychiatr Scand. 2000;101:416-432.
3. Coccurello R, Moles A. Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. Pharmacol Ther. 2010;127(3):210-251.
4. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752-1761. (Pubitemid 40385531)
5. Vik-Mo AO, Birkenaes AB, FernL J et al. Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients. Int J Neuropsychopharmacol. 2008;11:679-684. (Pubitemid 351931824)
6. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145-171. (Pubitemid 32037503)
7. McIntyre RS, Jerrell JM. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch Pediatr Adolesc Med. 2008;162:929-935.
8. Alvarez-Jimenez M, Gonzalez-Blanch C, Crespo-FacorroB, et al. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs. 2008;22(7):547-562. (Pubitemid 351822117)
9. Hemmrich K, Gummersbach C, Pallua N, et al. Clozapine enhances differentiation of adipocyte progenitor cells. Mol Psychiatry. 2006;11:980-981. (Pubitemid 44631639)
10. Minet-Ringuet J, Even PC, Valet P, et al. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. Mol Psychiatry. 2007;12(6):562-571. (Pubitemid 46816768)
11. McQuade RD, Stock E, Marcus R, et al. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. J Clin Psychiatry. 2004;65(suppl 18): 47-56.
12. Fleischhacker WW, Heikkinen ME, Olié JP et al. Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. Int J Neuropsychopharmacol. 2010;13:1115-1125.
13. Choong E, Rudaz S, Kottelat A, et al. Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS. J Pharm Biomed Anal. 2009;50:1000-1008.
14. Ferno J, Vik-Mo AO, Jassim G, et al. Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology. 2009;203:73-84.
15. Raeder MB, Ferno J, Glambek M, et al. Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci Lett. 2006;395:185-190. (Pubitemid 43213141)
16. Aravagiri M, Teper Y, Marder SR. Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos. 1999;20:369-377. (Pubitemid 30449775)
17. Imhoff BR, Hansen JM. Extracellular redox environments regulate adipocyte differentiation. Differentiation. 2010;80:31-39.
18. Walss-Bass C, Weintraub ST, Hatch J, et al. Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations. Int J Neuropsychopharmacol. 2008;11: 1097-1104.
19. Martins MR, Petronilho FC, Gomes KM, et al. Antipsychotic-induced oxidative stress in rat brain. Neurotox Res. 2008;13:63-69.
20. Noble M, Smith J, Power J, et al. Redox state as a central modulator of precursor cell function. Ann N Y Acad Sci. 2003;991:251-271. (Pubitemid 36793819)
21. Lö ffler S, Klimke A, Kronenwett R, Kobbe G, Haas R, Fehsel K. Clozapine mobilizes CD34(+) hematopoietic stem and progenitor cells and increases plasma concentration of interleukin 6 in patients with schizophrenia. J Clin Psychopharmacol. 2010;30:591-595.